A Phase 1 interventional study of Lisdexamfetamine Dimesylate and Adderall XR (mixed salts amphetamine) in Healthy Volunteers, sponsored by Shire. Completed at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-14.
Sponsored by Shire (part of Takeda) · Phase 1, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to determine if taking Vyvanse with Prilosec OTC or Adderall XR with Prilosec OTC changes how quickly the drug is absorbed into the body and/or changes how much of the drug is absorbed into the body.
Shire is the lead sponsor of 351 studies on the registry; 2 are open to participants now.
Of its 48 completed or terminated interventional studies of FDA-regulated products, 48 (100%) have results posted.
First submitted before Shire became part of Takeda.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Lisdexamfetamine Dimesylate
Drug: Adderall XR (mixed salts amphetamine)
50mg capsule
20mg capsule
Maximum Plasma Concentration (Cmax) of d-Amphetamine for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC
d-Amphetamine is an isomer of Vyvanse and Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
Time frame: 0 through 96 hours after dosing
Time of Maximum Plasma Concentration (Tmax) of d-Amphetamine for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC
d-Amphetamine is an isomer of Vyvanse and Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
Time frame: 0 through 96 hours after dosing
Area Under the Steady-state Plasma Concentration-time Curve (AUC) of d-Amphetamine for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC
d-Amphetamine is an isomer of Vyvanse and Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
Time frame: 0 through 96 hours after dosing
Terminal Half-life (T 1/2) of d-Amphetamine for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC
d-Amphetamine is an isomer of Vyvanse and Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
Time frame: 0 through 96 hours after dosing
Cmax of l-Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC
l-Amphetamine is an isomer of Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
Time frame: 0 through 96 hours after dosing
Tmax of l-Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC
l-Amphetamine is an isomer of Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
Time frame: 0 through 96 hours after dosing
AUC of l-Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC
Time frame: 0 through 96 hours after dosing
T 1/2 of l-Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC
l-Amphetamine is an isomer of Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
Time frame: 0 through 96 hours after dosing
Cmax of Total Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC
Total amphetamine is the d- and l-amphetamines.
Time frame: 0 through 96 hours after dosing
Tmax of Total Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC
Total amphetamine is the d- and l-amphetamines.
Time frame: 0 through 96 hours after dosing
AUC of Total Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC
Total amphetamine is the d- and l-amphetamines.
Time frame: 0 through 96 hours after dosing
T 1/2 of Total Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC
Total amphetamine is the d- and l-amphetamines.
Time frame: 0 through 96 hours after dosing
Drug Rating Questionnaire-Subject (DRQ-S), Question 2, for Vyvanse and Adderall XR in Combination With Prilosec OTC.
Question 2: How much do you like the effects you are feeling now? Questions are rated on a 29-point scale from 1 (not at all) to 29 (an awful lot). The higher the score the stronger the subjective experience. This is a subjective measure of a drug's effect that has been used to assess the abuse potential of drugs.
Time frame: Pre-dose and 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12 and 24 hours after dosing
DRQ-S, Question 1, for Vyvanse and Adderall XR in Combination With Prilosec OTC
Question 1: How much do you feel the drug now? Questions are rated on a 29-point scale from 1 (not at all) to 29 (an awful lot). The higher the score the stronger the subjective experience. This is a subjective measure of a drug's effect that has been used to assess the abuse potential of drugs.
Time frame: Pre-dose and 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12 and 24 hours after dosing
DRQ-S, Question 3, for Vyvanse and Adderall XR in Combination With Prilosec OTC
Question 3: Do you dislike the drug effect you are feeling now? Questions are rated on a 29-point scale from 1 (not at all) to 29 (an awful lot). The higher the score the stronger the subjective experience. This is a subjective measure of a drug's effect that has been used to assess the abuse potential of drugs.
Time frame: Pre-dose and 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12 and 24 hours after dosing
Systolic Blood Pressure for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC
Time frame: Pre-dose and 1, 2, 4, 8, 12, 24, 48, 72 and 96 hours after dosing
Diastolic Blood Pressure for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC
Time frame: Pre-dose and 1, 2, 4, 8, 12, 24, 48, 72 and 96 hours after dosing
Pulse Rate for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC
Time frame: Pre-dose and 1, 2, 4, 8, 12, 24, 48, 72 and 96 hours after dosing
Electrocardiogram Results (QTcF Interval) for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC
QTcF is the QT interval using Fridericia's correction formula. QT interval is a measure of time between the start of the Q wave and the end of the T wave and is dependent on the heart rate(e.g., the faster the heart rate, the shorter the QT interval). The QT interval has to be corrected in order to aid interpretation.
Time frame: Pre-dose, 2 and 8 hours after dosing
| Milestone | Vyvanse First | Adderall XR First |
|---|---|---|
| Started | 12 | 12 |
| Completed | 12 | 12 |
| Not completed | 0 | 0 |
| Milestone | Vyvanse First | Adderall XR First |
|---|---|---|
| Started | 12 | 12 |
| Completed | 11 | 12 |
| Not completed | 1 | 0 |
| Withdrew: Adverse event | 1 | 0 |
| Milestone | Vyvanse First | Adderall XR First |
|---|---|---|
| Started | 11 | 12 |
| Completed | 10 | 11 |
| Not completed | 1 | 1 |
| Withdrew: Withdrawal by subject | 1 | 1 |
| Milestone | Vyvanse First | Adderall XR First |
|---|---|---|
| Started | 10 | 11 |
| Completed | 10 | 11 |
| Not completed | 0 | 0 |
d-Amphetamine is an isomer of Vyvanse and Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
| ng/ml | Vyvanse | Adderall XR | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|---|---|
| Maximum Plasma Concentration (Cmax) of d-Amphetamine for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC | 45.04 ± 13.971 | 28.66 ± 7.174 | 46.34 ± 9.710 | 29.97 ± 5.719 |
Question 2: How much do you like the effects you are feeling now? Questions are rated on a 29-point scale from 1 (not at all) to 29 (an awful lot). The higher the score the stronger the subjective experience. This is a subjective measure of a drug's effect that has been used to assess the abuse potential of drugs.
| units on a scale | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|
| Pre-dose | 1.0 ± 0.0 | 1.0 ± 0.0 |
| 0.5 h | 1.2 ± 0.60 | 2.0 ± 3.09 |
| 1 h | 1.8 ± 1.75 | 2.0 ± 3.08 |
| 1.5 h | 4.6 ± 8.28 | 2.2 ± 3.56 |
| 2 h | 4.6 ± 8.33 | 2.5 ± 4.56 |
| 2.5 h | 3.9 ± 6.04 | 2.3 ± 3.73 |
| 3 h | 3.5 ± 5.78 | 1.5 ± 1.03 |
| 3.5 h | 2.7 ± 3.78 | 1.3 ± 0.80 |
| 4 h | 1.7 ± 1.06 | 1.4 ± 0.86 |
| 5 h | 2.4 ± 3.93 | 1.3 ± 0.72 |
| 6 h | 1.4 ± 0.81 | 1.2 ± 0.51 |
| 8 h | 1.4 ± 0.74 | 1.3 ± 1.32 |
| 12 h | 1.2 ± 0.62 | 1.1 ± 0.36 |
| 24 h | 1.3 ± 0.72 | 1.0 ± 0.22 |
Question 1: How much do you feel the drug now? Questions are rated on a 29-point scale from 1 (not at all) to 29 (an awful lot). The higher the score the stronger the subjective experience. This is a subjective measure of a drug's effect that has been used to assess the abuse potential of drugs.
| units on a scale | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|
| Pre-dose | 1.0 ± 0.0 | 1.0 ± 0.0 |
| 0.5 h | 1.3 ± 0.73 | 1.3 ± 0.66 |
| 1 h | 2.1 ± 2.66 | 1.9 ± 2.46 |
| 1.5 h | 5.2 ± 8.38 | 2.3 ± 2.97 |
| 2 h | 6.0 ± 8.69 | 3.5 ± 5.33 |
| 2.5 h | 6.0 ± 7.59 | 3.5 ± 4.64 |
| 3 h | 5.3 ± 6.72 | 2.7 ± 3.36 |
| 3.5 h | 4.9 ± 6.09 | 2.1 ± 2.01 |
| 4 h | 3.8 ± 4.57 | 2.1 ± 1.84 |
| 5 h | 3.1 ± 4.13 | 1.9 ± 1.74 |
| 6 h | 3.4 ± 3.60 | 1.5 ± 0.87 |
| 8 h | 3.0 ± 4.26 | 1.3 ± 0.66 |
| 12 h | 4.4 ± 7.19 | 1.2 ± 0.54 |
| 24 h | 1.6 ± 1.40 | 1.0 ± 0.22 |
Question 3: Do you dislike the drug effect you are feeling now? Questions are rated on a 29-point scale from 1 (not at all) to 29 (an awful lot). The higher the score the stronger the subjective experience. This is a subjective measure of a drug's effect that has been used to assess the abuse potential of drugs.
| units on a scale | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|
| Pre-dose | 1.0 ± 0.0 | 1.0 ± 0.0 |
| 0.5 h | 2.0 ± 3.49 | 2.1 ± 3.11 |
| 1 h | 1.8 ± 1.67 | 2.0 ± 3.08 |
| 1.5 h | 4.3 ± 8.03 | 1.8 ± 1.55 |
| 2 h | 4.5 ± 8.37 | 1.4 ± 0.93 |
| 2.5 h | 3.8 ± 6.39 | 1.4 ± 0.80 |
| 3 h | 3.4 ± 5.78 | 1.2 ± 0.54 |
| 3.5 h | 2.6 ± 3.54 | 1.3 ± 0.72 |
| 4 h | 1.8 ± 1.18 | 1.3 ± 0.80 |
| 5 h | 2.3 ± 4.13 | 1.3 ± 0.97 |
| 6 h | 1.6 ± 1.02 | 1.2 ± 0.70 |
| 8 h | 1.6 ± 1.78 | 1.1 ± 0.48 |
| 12 h | 1.3 ± 0.80 | 1.2 ± 0.51 |
| 24 h | 1.1 ± 0.48 | 1.0 ± 0.22 |
| mmHg | Vyvanse | Adderall XR | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|---|---|
| Pre-dose | 115.6 ± 10.79 | 115.3 ± 10.26 | 114.8 ± 11.29 | 113.9 ± 11.71 |
| 1 h | 122.8 ± 11.10 | 121.0 ± 10.46 | 121.7 ± 13.31 | 122.6 ± 9.67 |
| 2 h | 127.9 ± 12.81 | 122.2 ± 11.34 | 125.5 ± 10.14 | 124.7 ± 12.74 |
| 4 h | 127.6 ± 12.95 | 120.8 ± 11.71 | 125.2 ± 11.50 | 124.2 ± 9.75 |
| 8 h | 126.0 ± 12.69 | 122.4 ± 11.04 | 123.5 ± 13.25 | 119.2 ± 10.99 |
| 12 h | 123.4 ± 15.62 | 121.9 ± 12.04 | 122.2 ± 13.19 | 118.4 ± 10.58 |
| 24 h | 114.0 ± 11.68 | 118.1 ± 12.97 | 114.7 ± 11.19 | 115.6 ± 13.42 |
| 48 h | 114.6 ± 12.84 | 112.6 ± 10.56 | 114.4 ± 10.81 | 113.6 ± 11.01 |
| 72 h | 113.7 ± 10.25 | 114.8 ± 11.81 | 115.1 ± 11.71 | 116.0 ± 9.74 |
| 96 h | 114.0 ± 10.53 | 114.5 ± 10.72 | 114.8 ± 11.06 | 116.1 ± 9.29 |
d-Amphetamine is an isomer of Vyvanse and Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
| h | Vyvanse | Adderall XR | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|---|---|
| Time of Maximum Plasma Concentration (Tmax) of d-Amphetamine for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC | 3.5 ± 1.14 | 5.2 ± 3.10 | 3.5 ± 0.97 | 3.3 ± 1.45 |
d-Amphetamine is an isomer of Vyvanse and Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
| ng.h/ml | Vyvanse | Adderall XR | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|---|---|
| Area Under the Steady-state Plasma Concentration-time Curve (AUC) of d-Amphetamine for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC | 626.27 ± 198.982 | 473.70 ± 71.043 | 687.00 ± 196.906 | 472.35 ± 108.891 |
d-Amphetamine is an isomer of Vyvanse and Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
| h | Vyvanse | Adderall XR | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|---|---|
| Terminal Half-life (T 1/2) of d-Amphetamine for Vyvanse and Adderall XR Alone and in Combination With Prilosec OTC | 9.7 ± 1.55 | 10.25 ± 1.36 | 10.4 ± 1.65 | 10.91 ± 1.95 |
| mmHg | Vyvanse | Adderall XR | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|---|---|
| Pre-dose | 76.0 ± 6.68 | 74.1 ± 6.72 | 77.7 ± 8.60 | 75.8 ± 7.80 |
| 1 h | 79.2 ± 6.62 | 76.4 ± 5.98 | 80.5 ± 9.52 | 80.4 ± 6.29 |
| 2 h | 79.0 ± 6.97 | 75.4 ± 6.58 | 82.0 ± 6.44 | 81.9 ± 8.71 |
| 4 h | 79.9 ± 7.91 | 77.7 ± 6.31 | 82.0 ± 7.68 | 82.0 ± 7.09 |
| 8 h | 78.6 ± 7.87 | 74.1 ± 5.73 | 80.3 ± 9.54 | 79.2 ± 7.96 |
| 12 h | 79.6 ± 9.45 | 78.5 ± 8.29 | 78.7 ± 10.47 | 77.8 ± 8.20 |
| 24 h | 75.9 ± 6.76 | 76.8 ± 8.62 | 75.0 ± 7.76 | 75.4 ± 7.30 |
| 48 h | 74.5 ± 8.39 | 73.5 ± 8.40 | 77.2 ± 6.53 | 74.4 ± 8.01 |
| 72 h | 75.1 ± 7.97 | 74.7 ± 7.24 | 76.1 ± 7.58 | 77.9 ± 6.77 |
| 96 h | 74.5 ± 8.02 | 75.7 ± 7.65 | 75.7 ± 7.48 | 78.3 ± 6.96 |
| bpm | Vyvanse | Adderall XR | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|---|---|
| Pre-dose | 70.9 ± 9.87 | 69.0 ± 8.87 | 73.3 ± 10.16 | 71.4 ± 10.14 |
| 1 h | 69.7 ± 10.61 | 70.0 ± 11.29 | 73.4 ± 10.91 | 73.8 ± 13.78 |
| 2 h | 78.2 ± 11.64 | 75.2 ± 10.85 | 83.4 ± 14.68 | 80.5 ± 16.87 |
| 4 h | 79.0 ± 14.40 | 74.5 ± 12.62 | 84.4 ± 16.29 | 78.4 ± 15.03 |
| 8 h | 84.8 ± 11.38 | 79.1 ± 10.70 | 87.7 ± 14.34 | 81.5 ± 11.50 |
| 12 h | 86.4 ± 13.84 | 82.3 ± 14.12 | 89.1 ± 13.77 | 82.7 ± 10.99 |
| 24 h | 79.9 ± 11.19 | 74.7 ± 12.58 | 80.4 ± 11.32 | 76.4 ± 12.06 |
| 48 h | 73.2 ± 11.28 | 74.0 ± 11.02 | 75.1 ± 10.32 | 75.0 ± 9.46 |
| 72 h | 72.2 ± 10.63 | 73.3 ± 9.16 | 72.0 ± 7.99 | 72.7 ± 8.78 |
| 96 h | 70.7 ± 10.64 | 70.4 ± 9.11 | 72.5 ± 10.12 | 73.9 ± 9.86 |
QTcF is the QT interval using Fridericia's correction formula. QT interval is a measure of time between the start of the Q wave and the end of the T wave and is dependent on the heart rate(e.g., the faster the heart rate, the shorter the QT interval). The QT interval has to be corrected in order to aid interpretation.
| msec | Vyvanse | Adderall XR | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|---|---|
| Pre-dose | 399.8 ± 14.55 | 398.3 ± 15.24 | 399.3 ± 13.38 | 399.8 ± 15.04 |
| 2 h | 395.0 ± 14.11 | 394.6 ± 13.42 | 397.9 ± 13.86 | 396.1 ± 14.49 |
| 8 h | 390.0 ± 12.45 | 393.8 ± 13.94 | 395.4 ± 14.93 | 394.4 ± 13.26 |
l-Amphetamine is an isomer of Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
| ng/ml | Adderall XR | Adderall XR + Prilosec OTC |
|---|---|---|
| Cmax of l-Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC | 7.91 ± 2.022 | 8.10 ± 1.632 |
l-Amphetamine is an isomer of Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
| h | Adderall XR | Adderall XR + Prilosec OTC |
|---|---|---|
| Tmax of l-Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC | 5.6 ± 3.0 | 3.5 ± 1.74 |
| ng.h/ml | Adderall XR | Adderall XR + Prilosec OTC |
|---|---|---|
| AUC of l-Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC | 145.28 ± 24.355 | 145.83 ± 38.233 |
l-Amphetamine is an isomer of Adderall XR and is an active form that is responsible for the drug's therapeutic activity.
| h | Adderall XR | Adderall XR + Prilosec OTC |
|---|---|---|
| T 1/2 of l-Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC | 11.98 ± 1.92 | 13.06 ± 2.63 |
Total amphetamine is the d- and l-amphetamines.
| ng/ml | Adderall XR | Adderall XR + Prilosec OTC |
|---|---|---|
| Cmax of Total Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC | 36.56 ± 9.188 | 38.05 ± 7.351 |
Total amphetamine is the d- and l-amphetamines.
| h | Adderall XR | Adderall XR + Prilosec OTC |
|---|---|---|
| Tmax of Total Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC | 5.30 ± 3.07 | 3.29 ± 1.45 |
Total amphetamine is the d- and l-amphetamines.
| ng.h/ml | Adderall XR | Adderall XR + Prilosec OTC |
|---|---|---|
| AUC of Total Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC | 620.68 ± 95.689 | 620.91 ± 145.378 |
Total amphetamine is the d- and l-amphetamines.
| h | Adderall XR | Adderall XR + Prilosec OTC |
|---|---|---|
| T 1/2 of Total Amphetamine for Adderall XR Alone and in Combination With Prilosec OTC | 10.38 ± 1.56 | 11.05 ± 2.22 |
Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Vyvanse | — | 0/24 (0%) | 8/24 (33.3%) |
| Adderall XR | — | 0/23 (0%) | 3/23 (13%) |
| Vyvanse + Prilosec OTC | — | 0/21 (0%) | 10/21 (47.6%) |
| Adderall XR + Prilosec OTC | — | 0/21 (0%) | 3/21 (14.3%) |
| Event | Vyvanse | Adderall XR | Vyvanse + Prilosec OTC | Adderall XR + Prilosec OTC |
|---|---|---|---|---|
| AnxietyPsychiatric disorders | 2/24 | 2/23 | 8/21 | 0/21 |
| VasospasmVascular disorders | 0/24 | 0/23 | 4/21 | 3/21 |
| HeadacheNervous system disorders | 1/24 | 0/23 | 3/21 | 0/21 |
| DizzinessNervous system disorders | 1/24 | 0/23 | 2/21 | 0/21 |
| PalpitationsCardiac disorders | 2/24 | 1/23 | 0/21 | 0/21 |
| TachycardiaCardiac disorders | 2/24 | 0/23 | 0/21 | 0/21 |
| Age, Categorical(Participants) | Entire Study Population |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 24 |
| >=65 years | 0 |
| Age, Continuous(years) | Entire Study Population |
|---|---|
| Mean | 37.7 ± 6.54 |
| Sex: Female, Male(Participants) | Entire Study Population |
|---|---|
| Female | 6 |
| Male | 18 |
| Region of Enrollment(Participants) | Entire Study Population |
|---|---|
| United States | 24 |
Ran from Sep 2008 to primary completion in Oct 2008, 1 month.
Results were first posted in Nov 2009, 1 year after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Lisdexamfetamine · Adderall